Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis.

about

Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses.

P2860

Q38183850-9E53650A-8EE3-4C8E-BDA4-7ACEDA258C3B Q44916496-569F6DA3-3EC4-46AF-AF57-41F9C47F2A2A

P2860

Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis.

Item

http://www.wikidata.org/entity/Q39663158

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@en

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@nl

type

Item

label

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@en

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@nl

prefLabel

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@en

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@nl

P1476

Influence of non-toxic doses o ...... nd inhibition of angiogenesis.

@en

P2093

Adiel Barak

http://www.w3.org/2001/XMLSchema#string

Anat Lowenstein

http://www.w3.org/2001/XMLSchema#string

Aya Barzelay

http://www.w3.org/2001/XMLSchema#string

P2860

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Angiogenesis in health and disease

Ranibizumab for neovascular age-related macular degeneration

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

In vitro models of vasculogenesis and angiogenesis.

Inhibition of angiogenesis by non-toxic doses of temozolomide.

Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.

Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer.

P304

835-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02713683.2010.489727

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacob George

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20795866

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

bevacizumab

Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis.

about

P2860

P2860

Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921